Apimeds Pharmaceuticals US Inc
AMEX:APUS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Apimeds Pharmaceuticals US Inc
AMEX:APUS
|
US |
|
Vallourec SA
OTC:VLOUF
|
FR |
|
S
|
Singapore Airlines Ltd
XMUN:SIA1
|
SG |
|
W
|
Western Uranium & Vanadium Corp
SWB:7WT
|
CA |
|
Macquarie Technology Group Ltd
ASX:MAQ
|
AU |
|
E
|
EdiliziAcrobatica SpA
PAR:ALEAC
|
IT |
|
Odessa Minerals Ltd
ASX:ODE
|
AU |
|
A
|
ALD SA
SWB:3AL
|
FR |
|
Golden Goliath Resources Ltd
F:GGZA
|
CA |
|
N
|
Ndfos Co Ltd
KOSDAQ:238090
|
KR |
|
Bekasi Asri Pemula Tbk PT
IDX:BAPA
|
ID |
|
Tecma Solutions SpA
MIL:TCM
|
IT |
|
E
|
Elia Group SA
DUS:E4S
|
BE |
|
I
|
Insulet Corp
XMUN:GOV
|
US |
|
Universal Music Group NV
AEX:UMG
|
NL |
Bankruptcy Probability
Apimeds Pharmaceuticals US Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Apimeds Pharmaceuticals US Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
A
|
Apimeds Pharmaceuticals US Inc
AMEX:APUS
|
4.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
504B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
242B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
195.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
135.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
80.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
57.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Apimeds Pharmaceuticals US Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Apimeds Pharmaceuticals US Inc has total debt of 13.9m USD. This includes both short-term (13.9m USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.